Health Care: Drugs

Rigel Pharmaceuticals Inc (RIGL: NASDAQ)

$2.39 n/a | n/a%
05/26/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 2.39
52 Week High 4.38
52 Week Low 1.94
Avg. Daily Vol. (Mil) 1.11
Beta (3 year) 1.21
Share Related Items
Mkt Cap (Mil) 292.62
Shares Out (Mil) 122.43
Float (Mil) 107.36
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.70
Current Ratio 5.80
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 15.45
Price/Book 3.48
Price/Cash Flow -4.40
Per Share Data
Earnings -0.67
Sales 0.15
Book Value 0.69
Cash Flow -0.54
Business Summary
Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company. It discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases.
General Information
1180 Veterans Boulevard
South San Francisco, CA 94080
Industry : Drugs
Sector: Health Care
Employees: 77
CEO: Raul R. Rodriguez
Short Interest
Current Month (Mil) 3.58
Previous Month (Mil) 3.69
Short Interest Ratio (Days) 5.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -66.20
Return on Investments -79.80
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with RIGL

Latest RIGL Headlines from TheStreet

More Financial News for RIGL

Press Releases for RIGL

See All Press Releases

Partner Headlines for RIGL

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter